May aid in the evaluation of lung inflammation or injury in various types of ILD.
New York DOH Approval Status
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1.5 mL serum to ARUP Standard Transport Tube. (Min: 0.5 mL)
Hemolyzed, hyperlipemic, icteric, heat-treated or contaminated.
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month
Krebs von den Lungen-6 (KL-6) is an indicator of lung inflammation or damage. Elevated levels are associated with various types of interstitial lung diseases (ILD).
Abnormal KL-6 results should be interpreted in the appropriate clinical context. A negative result does not rule out ILD.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Samples with results greater than 10,000 U/mL will be diluted to the maximum reportable range (>40,000 U/mL).
|Component Test Code*||Component Chart Name||LOINC|
|3001867||Krebs von den Lungen-6||93369-7|
- KL 6